Mortality in Parkinson's disease remains increased despite low dose levodopa-carbidopa therapy and no additional benefit was gained from early use of bromocriptine. Duration of disease was similar to that in the era before levodopa.
No takes yet. Share an insight, caveat, or question.
Hely et al. (1999) studied this question.